期刊文献+

葡萄糖-6-磷酸脱氢酶在糖尿病及其并发症中的作用及机制 被引量:5

The Role and Mechanism of Glucose-6-Phosphate Dehydrogenase in Diabetes and Its Complications
下载PDF
导出
摘要 葡萄糖-6-磷酸脱氢酶(G6PD)是磷酸戊糖途径的限速酶,对维持细胞内还原型烟酰胺腺嘌呤二核苷酸磷酸和氧化还原反应的平衡起着重要作用。G6PD缺乏症是人类最常见的遗传性细胞酶病,以往的研究多集中在溶血、贫血等方面。然而,近年来的研究发现G6PD在机体发育、多种疾病的发生和发展等方面也具有重要作用。 Glucose-6-phosphate dehydrogenase(G6PD) is the rate-limiting enzyme of the pentose phos-phate pathway,which plays an important role in the maintenance of intracellular reduced nicotinamide ade-nine dinucleotide phosphate and the balance of oxidation reduction.G6PD deficiency is the most common enzymopathies of the human in the world .The previous studies are mostly focused on hemolytic and anemia . However,recent studies show G6PD also plays an important role in the body development and is associated with a variety of diseases.
出处 《医学综述》 2015年第5期848-851,共4页 Medical Recapitulate
基金 国家自然科学基金(30900502) 上海市科委(11PJ1402000) 上海市卫生局(XYQ2011002)
关键词 糖尿病 葡萄糖-6-磷酸脱氢酶 氧化应激 并发症 Diabetes mellitus Glucose-6-phosphate dehydrogenase Oxidative stress Complications
  • 相关文献

二级参考文献14

  • 1Salati LM, Amir-Ahmady B. Dietary regulation of expression of glucose-6-phosphate dehydrogenase. Annu Rev Nutr 2001; 21: 121-140.
  • 2Xu Y, Zhang Z, Hu J, Stillman IE, Leopold JA, Handy DE, Loscalzo J, Stanton RC. Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria. FASEB J 2010; 24(2): 609-616.
  • 3Leopold JA, Walker J, Scribner AW, Voetsch B, Zhang YY, Loscalzo AJ, Stanton RC, Loscalzo J. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factormediated angiogenesis. J Biol Chem 2003; 278: 32100-32106.
  • 4Xu Y, Osborne BW, Stanton RC. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol Renal Physiol 2005; 289: F1040-F1047.
  • 5Zhang Z, Apse K, Pang J, Stanton RC. High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J Biol Chem 2000; 275: 40042-40047.
  • 6Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006; 114: 597-605.
  • 7Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-3561.
  • 8Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 2002; 1: 1.
  • 9Mamputu JC, Renier G. Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. J Leukoc Biol 2004: 75:1062-1069.
  • 10He M, Siow RC, Sugden D, Gao L, Cheng X, Mann GE. Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes. Nutri Metab Cardiovasc Dis 2011; 21(4): 277-285.

共引文献1

同被引文献68

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部